I liked this question from the website of the 2012 BIO International Convention because it suggests that anyone’s own background, identity or area of expertise is welcome for sharing at this meeting, which kicks off Monday among 15,000+ participants expected from 65 countries.
Biotechnology scientists, business leaders, investors, communicators and other stakeholders will converge and convene in Boston – already a true hub for biotechnology and health industries with 48,000 people in the area employed in the sciences.
Based on our analysis of BIO’s One-on-One Partnering™ System, the top 10 countries represented are:
BIO 2012 is all about connecting and partnering unique, leading science organizations to share insights surrounding research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO is clearly growing in diversity, with the U.S. now accounting for less than half of partnering country registrants.
On the program side, I’m personally excited about the Orphan Disease Forum on June 19, as it focuses on the issue of rare diseases, a cause dear to the heart of Spectrum and our GLOBALHealthPR partners. Among our work with various clients working on therapeutics in the rare disease category, we’ve dedicated ourselves to the Progeria Research Foundation to communicate awareness of this extremely rare disease that causes children to age rapidly, and help locate more children worldwide to provide them support and possibly enroll them in new studies for a treatment.
There’s lots more ahead in Boston at BIO 2012. Watch this space throughout the week for continued blog posts from me and live tweets (@JohnJSeng) during the conference.
How are you planning to connect with colleagues from around the globe?